Stock Update: Alexion Pharmaceuticals Inc (NASDAQ:ALXN) – Alexion to Highlight Innovative Rare Disease Portfolio at Investor Day Meeting

[Business Wire] – Alexion Pharmaceuticals, Inc. announced today that the Company will highlight significant progress in its early- and late-stage rare disease portfolio and provide updates on key aspects of its long-term growth . . . → Read More: Stock Update: Alexion Pharmaceuticals Inc (NASDAQ:ALXN) – Alexion to Highlight Innovative Rare Disease Portfolio at Investor Day Meeting Similar Articles: Stock Update: Alexion Pharmaceuticals Inc (NASDAQ:ALXN) – Alexion to Highlight Robust Rare Disease Pipeline at Investor Day Stock Update: Alexion Pharmaceuticals Inc (NASDAQ:ALXN) – Alexion Pharmaceuticals to Report Third Quarter 2015 Results on Thursday, October 29, 2015 Stock Update: Alexion Pharmaceuticals Inc (NASDAQ:ALXN) – Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) to Ring The Nasdaq Stock Market Closing Bell